8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.57%
Negative revenue growth while 3141.T stands at 7.29%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.27%
Negative gross profit growth while 3141.T is at 11.55%. Joel Greenblatt would examine cost competitiveness or demand decline.
-27.63%
Negative EBIT growth while 3141.T is at 78.64%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-30.80%
Negative operating income growth while 3141.T is at 99.75%. Joel Greenblatt would press for urgent turnaround measures.
-28.44%
Negative net income growth while 3141.T stands at 108.34%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-28.45%
Negative EPS growth while 3141.T is at 108.30%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-28.45%
Negative diluted EPS growth while 3141.T is at 108.30%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
86.76%
10Y revenue/share CAGR above 1.5x 3141.T's 15.74%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
86.76%
5Y revenue/share CAGR above 1.5x 3141.T's 15.74%. David Dodd would look for consistent product or market expansions fueling outperformance.
54.48%
3Y revenue/share CAGR above 1.5x 3141.T's 15.74%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 3Y OCF/share CAGR while 3141.T stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
206.94%
Net income/share CAGR at 50-75% of 3141.T's 308.58%. Martin Whitman might question if the firm’s product or cost base lags behind.
206.94%
5Y net income/share CAGR at 50-75% of 3141.T's 308.58%. Martin Whitman might see a shortfall in operational efficiency or brand power.
61.89%
Below 50% of 3141.T's 308.58%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
126.07%
10Y equity/share CAGR above 1.5x 3141.T's 33.16%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
126.07%
5Y equity/share CAGR above 1.5x 3141.T's 33.16%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.28%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
6.72%
Positive asset growth while 3141.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5.46%
Similar to 3141.T's 5.65%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-18.56%
We’re deleveraging while 3141.T stands at 9.17%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.